StonvexLoading…
StonvexStonvexStonvexCore line items from SLNH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $9.39M | $29.72M | $5.94M | $38.02M |
Operating Income | $-16.63M | $-33.68M | $-7.18M | $-47.52M |
Net Income | $-17.47M | $-53.41M | $-7.56M | $-63.33M |
EPS (Diluted) | $-0.24 | $-2.38 | $-1.21 | $-14.94 |
Total Assets | $190.42M | $187.94M | $90.05M | $88.04M |
Total Liabilities | $76.06M | $75.70M | $63.06M | $60.68M |
Cash & Equivalents | $68.57M | $76.42M | $9.16M | $7.84M |
Free Cash Flow OCF − CapEx | $-8.94M | $-37.21M | $-3.71M | $-13.92M |
Shares Outstanding | 111.72M | 102.53M | 12.51M | 10.61M |